Thank you, Sally, and good morning, good afternoon, good evening to all of our shareholders, and welcome to all to ResMed's second quarter fiscal year 2026 earnings call. For this March and the June ...
Over the past six years, we have aligned our portfolio to the fastest-growing defense priorities, with a vision of the future of warfare. This transaction enables us to sharpen our focus on our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results